A detailed history of Nordea Investment Management Ab transactions in Johnson & Johnson stock. As of the latest transaction made, Nordea Investment Management Ab holds 6,449,842 shares of JNJ stock, worth $1.07 Billion. This represents 1.14% of its overall portfolio holdings.

Number of Shares
6,449,842
Previous 7,654,016 15.73%
Holding current value
$1.07 Billion
Previous $1.21 Billion 22.14%
% of portfolio
1.14%
Previous 1.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $174 Million - $190 Million
-1,204,174 Reduced 15.73%
6,449,842 $943 Million
Q1 2024

May 02, 2024

SELL
$155.22 - $162.74 $48.9 Million - $51.2 Million
-314,815 Reduced 3.95%
7,654,016 $1.21 Billion
Q4 2023

Jan 10, 2024

SELL
$145.6 - $158.88 $101 Million - $110 Million
-691,973 Reduced 7.99%
7,968,831 $1.25 Billion
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $82.6 Million - $92.5 Million
-530,265 Reduced 5.77%
8,660,804 $1.35 Billion
Q2 2023

Jul 07, 2023

BUY
$154.35 - $166.11 $304 Million - $327 Million
1,969,230 Added 27.27%
9,191,069 $1.52 Billion
Q1 2023

Apr 19, 2023

BUY
$151.05 - $180.26 $10.5 Million - $12.5 Million
69,253 Added 0.97%
7,221,839 $1.12 Billion
Q4 2022

Feb 08, 2023

SELL
$160.2 - $179.79 $182 Million - $205 Million
-1,139,073 Reduced 13.74%
7,152,586 $1.26 Billion
Q3 2022

Oct 19, 2022

SELL
$161.33 - $179.52 $47.5 Million - $52.9 Million
-294,562 Reduced 3.43%
8,291,659 $1.37 Billion
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $95.2 Million - $105 Million
-565,907 Reduced 6.18%
8,586,221 $1.51 Billion
Q1 2022

Apr 11, 2022

SELL
$158.14 - $179.59 $195 Million - $222 Million
-1,233,563 Reduced 11.88%
9,152,128 $1.65 Billion
Q4 2021

Jan 20, 2022

BUY
$155.93 - $173.01 $80.5 Million - $89.3 Million
516,357 Added 5.23%
10,385,691 $1.79 Billion
Q3 2021

Nov 01, 2021

SELL
$161.5 - $179.47 $1.54 Billion - $1.71 Billion
-9,530,256 Reduced 49.13%
9,869,334 $1.62 Billion
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $1.58 Billion - $1.76 Billion
9,808,798 Added 102.27%
19,399,590 $3.13 Billion
Q2 2021

Jul 16, 2021

BUY
$159.48 - $171.07 $33.9 Million - $36.3 Million
212,371 Added 2.26%
9,590,792 $1.58 Billion
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $76.7 Million - $85.5 Million
501,358 Added 5.65%
9,378,421 $1.54 Billion
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $36.6 Million - $42 Million
267,138 Added 3.1%
8,877,063 $1.4 Billion
Q3 2020

Nov 09, 2020

SELL
$140.38 - $153.83 $1.21 Billion - $1.32 Billion
-8,612,237 Reduced 50.01%
8,609,925 $1.27 Billion
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $1.04 Billion - $1.25 Billion
8,062,204 Added 88.02%
17,222,162 $2.42 Billion
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $31.7 Million - $43.9 Million
284,801 Added 3.21%
9,159,958 $1.2 Billion
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $50.1 Million - $57.5 Million
-392,885 Reduced 4.24%
8,875,157 $1.29 Billion
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $82.2 Million - $92 Million
647,217 Added 7.51%
9,268,042 $1.2 Billion
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $11.6 Million - $12.8 Million
-88,589 Reduced 1.02%
8,620,825 $1.2 Billion
Q1 2019

May 20, 2019

BUY
$125.72 - $139.79 $136 Million - $151 Million
1,079,751 Added 14.15%
8,709,414 $1.22 Billion
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $30.9 Million - $37.2 Million
-251,773 Reduced 3.19%
7,629,663 $985 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $67.5 Million - $79.3 Million
555,024 Added 7.58%
7,881,436 $1.09 Billion
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $30.9 Million - $34.1 Million
258,609 Added 3.66%
7,326,412 $889 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $178 Million - $211 Million
1,423,134 Added 25.21%
7,067,803 $906 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $25.2 Million - $27.6 Million
-192,329 Reduced 3.29%
5,644,669 $789 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $756 Million - $790 Million
5,836,998
5,836,998 $759 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $433B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.